Cite

HARVARD Citation

    Arends, P. et al. (2015). Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians. Gut. 64 (8), pp. 1289-1295. [Online]. 
  
Back to record